Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Gastroparesis refractory to prokinetics: neuromuscolar unresponsiveness or faulty bioavailability of the drug?

Bortolotti M, Gentilini L, Morselli C, Giovannini M, Miglioli M.

Dig Dis Sci. 2005 May;50(5):882-4. No abstract available.

PMID:
15906763
2.

Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.

Onoma M, Yogo K, Ozaki K, Kamei K, Akima M, Koga H, Itoh Z, Omura S, Takanashi H.

Clin Exp Pharmacol Physiol. 2008 Jan;35(1):35-42.

PMID:
18047625
3.

Safety of treatment for gastroparesis.

Sarosiek I, Bashashati M, McCallum RW.

Expert Opin Drug Saf. 2016 Jul;15(7):937-45. doi: 10.1517/14740338.2016.1173204. Epub 2016 Apr 21. Review.

PMID:
27031006
4.

Metoclopramide-stimulated gastric emptying scintigraphy: does it predict symptom response to prokinetic therapy in chronic gastroparesis?

Lyday WD 2nd, DiBaise JK.

Am J Gastroenterol. 2002 Sep;97(9):2474-6. No abstract available.

PMID:
12358283
5.

Postprandial function in gastroparesis.

Camilleri M.

Gut. 1995 May;36(5):798-9. No abstract available.

6.

Future directions in the treatment of gastroparesis.

Pasricha PJ.

Gastroenterol Clin North Am. 2015 Mar;44(1):185-9. doi: 10.1016/j.gtc.2014.11.014. Epub 2014 Dec 20. Review.

PMID:
25667032
7.

Effects of octreotide and erythromycin on gastric myoelectrical and motor activities in patients with gastroparesis.

Chen JD, Lin ZY, Edmunds MC 3rd, McCallum RW.

Dig Dis Sci. 1998 Jan;43(1):80-9.

PMID:
9508540
8.

Current treatment of nausea and vomiting associated with gastroparesis: antiemetics, prokinetics, tricyclics.

Stapleton J, Wo JM.

Gastrointest Endosc Clin N Am. 2009 Jan;19(1):57-72, vi. doi: 10.1016/j.giec.2008.12.008. Review.

PMID:
19232281
9.

Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.

Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J, Peeters T.

Aliment Pharmacol Ther. 2005 Nov 1;22(9):847-53.

10.

Prokinetics in gastroparesis.

Acosta A, Camilleri M.

Gastroenterol Clin North Am. 2015 Mar;44(1):97-111. doi: 10.1016/j.gtc.2014.11.008. Epub 2014 Dec 23. Review.

PMID:
25667026
11.

Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment.

Kim SW, Shin IS, Kim JM, Kang HC, Mun JU, Yang SJ, Yoon JS.

Psychosomatics. 2006 Sep-Oct;47(5):440-2.

PMID:
16959934
12.

Gastric electrical stimulation for the treatment of diabetic gastroparesis.

Guerci B, Bourgeois C, Bresler L, Scherrer ML, Böhme P.

Diabetes Metab. 2012 Nov;38(5):393-402. doi: 10.1016/j.diabet.2012.05.001. Epub 2012 Jun 27. Review.

PMID:
22742875
13.

Current advances in treatment of gastroparesis.

Malamood M, Parkman H, Schey R.

Expert Opin Pharmacother. 2015;16(13):1997-2008. doi: 10.1517/14656566.2015.1070829. Epub 2015 Jul 20. Review.

PMID:
26190775
14.

Upper GI Disorders: Pathophysiology and Current Therapeutic Approaches.

Parkman HP.

Handb Exp Pharmacol. 2017;239:17-37. doi: 10.1007/164_2016_114. Review.

PMID:
28105529
15.

Pharmacotherapy of gastroparesis.

Reddymasu SC, McCallum RW.

Expert Opin Pharmacother. 2009 Feb;10(3):469-84. doi: 10.1517/14656560902722505 . Review.

PMID:
19191682
16.

[Pathomechanisms of functional gastroparesis].

Sobocki J, Królczyk G, Thor PJ.

Folia Med Cracov. 2006;47(1-4):51-9. Review. Polish.

PMID:
18038612
17.
18.

Gastroparesis: separate entity or just a part of dyspepsia?

Stanghellini V, Tack J.

Gut. 2014 Dec;63(12):1972-8. doi: 10.1136/gutjnl-2013-306084. Epub 2014 Sep 26.

PMID:
25260920
20.

The stimulation of antral motility by erythromycin is attenuated by hyperglycemia.

Rayner CK, Su YC, Doran SM, Jones KL, Malbert CH, Horowitz M.

Am J Gastroenterol. 2000 Sep;95(9):2233-41.

PMID:
11007223

Supplemental Content

Support Center